Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Early Augmentation Response with Low-frequency Repetitive Transcranial Magnetic Stimulation in Treatment Resistant Depression

Singh J, Singh A, Kar SK, Pahuja E

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):197-198.
  • doi: 10.9758/cpn.2017.15.2.197
No abstract available.
Tardive Dyskinesia Associated with Bupropion

Tuman TC, Çakır U, Yıldırım O, Camkurt MA

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):194-196.
  • doi: 10.9758/cpn.2017.15.2.194
Present report describes a 46 year old male patient with a diagnosis of major depression who developed tardive dyskinesia during bupropion therapy. Our patient had no history of neuroleptic use...
Low-dose Clozapine-induced Seizure: A Case Report

Bolu A, Akarsu S, Pan E, Aydemir E, Oznur T

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):190-193.
  • doi: 10.9758/cpn.2017.15.2.190
Seizures are believed to be a dose-dependent side effect of clozapine. In this case report, we describe a patient who had tonic-clonic seizures after using a low dose clozapine who...
Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder

Ghosh S, Bhuyan D

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):187-189.
  • doi: 10.9758/cpn.2017.15.2.187
Baclofen is a gamma-aminobutyric acid type B receptor agonist used as an anti-craving agent for treatment of alcohol dependence. It has gained popularity in the recent times because it is...
Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report

Cicek E, Cicek IE, Uguz F

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):184-186.
  • doi: 10.9758/cpn.2017.15.2.184
Peripheral edema is observed as an adverse effect of the usage of antipsychotics in the literature. This case report describes a 36-year-old female patient with the diagnosis of paranoid schizophrenia...
Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine

Camkurt MA, Gülpamuk , Fındiklı E, Elve R

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):181-183.
  • doi: 10.9758/cpn.2017.15.2.181
Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after...
Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea

Woo YS, Shim IH, Lee SY, Lee DB, Kim MD, Jung YE, Lee J, Won S, Jon DI, Bahk WM

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):177-180.
  • doi: 10.9758/cpn.2017.15.2.177
OBJECTIVE: Although aripiprazole has been widely used to treat various psychiatric disorders, little is known about the adequate dosage for Asian patients in clinical practice. Hence, we evaluated the initial...
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor in Bipolar Mania: An Exploratory Study

Maiti R, Mishra BR, Jowhar J, Mohapatra , Parida S, Bisoi D

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):170-176.
  • doi: 10.9758/cpn.2017.15.2.170
OBJECTIVE: In bipolar disorder, serum brain-derived neurotrophic factor (BDNF) level decreases leading to dysfunctions of critical neurotrophic, cellular plasticity and neuroprotective processes. The present study was conducted to evaluate the...
Dehydroepiandrosterone Sulfate Level Varies Nonlinearly with Symptom Severity in Major Depressive Disorder

Uh D, Jeong HG, Choi KY, Oh SY, Lee S, Kim SH, Joe SH

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):163-169.
  • doi: 10.9758/cpn.2017.15.2.163
OBJECTIVE: The pathophysiology of major depressive disorder (MDD) is still not well understood. Conflicting results for surrogate biomarkers in MDD have been reported, which might be a consequence of the...
Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders

Karadag F, Sengul CB, Enli Y, Karakulah , Alacam H, Kaptanoglu B, Kalkanci O, Herken H

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):153-162.
  • doi: 10.9758/cpn.2017.15.2.153
OBJECTIVE: We investigated the relationship between serum bilirubin levels and metabolic syndrome (MetS), and the longitudinal effects of baseline serum bilirubin concentrations on MetS in patients with schizophrenia spectrum disorders...
Longer Telomere Length of T lymphocytes in Patients with Early and Chronic Psychosis

Cui Y, Prabhu VV, Nguyen TB, Devi SM, Chung YC

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):146-152.
  • doi: 10.9758/cpn.2017.15.2.146
OBJECTIVE: To investigate pathological conditions that act as sources of pro-inflammatory cytokines and cytotoxic substances to examine telomere length (TL) in patients with either early (duration of illness [DI] ≤5...
Differences in Resting-state Quantitative Electroencephalography Patterns in Attention Deficit/Hyperactivity Disorder with or without Comorbid Symptoms

Kim JW, Kim SY, Choi JW, Kim KM, Nam SH, Min KJ, Lee YS, Choi TY

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):138-145.
  • doi: 10.9758/cpn.2017.15.2.138
OBJECTIVE: The aim of the present study was to evaluate the role of comorbid psychiatric symptoms on quantitative electroencephalogram (QEEG) activities in boys with the attention deficit/hyperactivity disorder (ADHD). METHODS: All participants...
Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia

Hatano M, Kamei H, Kato A, Takeuchi I, Hanya M, Uno J, Yamada S, Fujita K, Iwata N

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):132-137.
  • doi: 10.9758/cpn.2017.15.2.132
OBJECTIVE: The adverse effects of antipsychotic agents can have a marked influence on medication adherence. In this study, we investigated the adverse events of antipsychotics that are less likely to...
Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial

Kang HJ, Bae KY, Kim SW, Shin IS, Hong YJ, Ahn Y, Jeong MH, Yoon JS, Kim JM

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):126-131.
  • doi: 10.9758/cpn.2017.15.2.126
OBJECTIVE: There are no evidence-based practices for treating anxiety in patients with acute coronary syndrome (ACS). Thus, we investigated the effects of escitalopram on anxiety in this population. METHODS: We enrolled...
In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology

Agrawal R, Kalmady SV, Venkatasubramanian G

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):115-125.
  • doi: 10.9758/cpn.2017.15.2.115
OBJECTIVE: Deficient brain-derived neurotrophic factor (BDNF) is one of the important mechanisms underlying the neuroplasticity abnormalities in schizophrenia. Aberration in BDNF signaling pathways directly or circuitously influences neurotransmitters like glutamate...
Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications

Muneer A

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):100-114.
  • doi: 10.9758/cpn.2017.15.2.100
The neurobiology of bipolar disorder, a chronic and systemic ailment is not completely understood. The bipolar phenotype manifests in myriad ways, and psychopharmacological agents like lithium have long term beneficial...
Role of Sleep Disturbance in the Trajectory of Alzheimer's Disease

Kang DW, Lee CU, Lim HK

  • Clin Psychopharmacol Neurosci.
  • 2017 May;15(2):89-99.
  • doi: 10.9758/cpn.2017.15.2.89
Sleep disturbances such as insomnia, hypersomnia, and circadian rhythm disturbance are common in normal elderly and Alzheimer's disease (AD) patients. To date, special attention has been paid to sleep disturbance...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr